Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 127641, 9 pages
http://dx.doi.org/10.1155/2011/127641
Research Article

Antiatherosclerotic Potential of Active Principle Isolated from Eugenia jambolana in Streptozotocin-Induced Diabetic Rats

1Department of Biochemistry, University College of Medical Sciences, University of Delhi, Delhi 110095, India
2Department of Pathology, University College of Medical Sciences, University of Delhi, Delhi 110095, India

Received 2 July 2010; Revised 25 November 2010; Accepted 15 February 2011

Copyright © 2011 Reenu Singh Tanwar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. K. Nadkarni, Indian Materia Medica, vol. 1, Popular Prakashan, Bombay, India, 1954.
  2. D. S. Shrotri, M. Kelkar, V. K. Deshmukh, and R. Aiman, “Investigation of the hypoglycemic properties of Vinca rosea, Cassia auriculata and Eugenia jambolana,” Indian Journal of Medical Research, vol. 51, pp. 464–467, 1963. View at Google Scholar
  3. R. Bansal, N. Ahmad, and J. R. Kidwai, “Effects of oral administration of Eugenia jambolana seeds and chloropropamide on blood glucose level and pancreatic cathepsin B in rat,” Indian Journal of Biochemistry and Biophysics, vol. 18, no. 5, pp. 377–381, 1981. View at Google Scholar · View at Scopus
  4. S. Achrekar, G. S. Kaklij, M. S. Pote, and S. M. Kelkar, “Hypoglycemic activity of Eugenia jambolana and Ficus bengalensis: Mechanism of action,” In Vivo, vol. 5, no. 2, pp. 143–147, 1991. View at Google Scholar · View at Scopus
  5. J. K. Grover, V. Vats, and S. S. Rathi, “Antihyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism,” Journal of Ethnopharmacology, vol. 73, pp. 461–470, 2000. View at Google Scholar
  6. V. Vikrant, J. K. Grover, N. Tandon, S. S. Rathi, and N. Gupta, “Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats,” Journal of Ethnopharmacology, vol. 76, no. 2, pp. 139–143, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. B. Sharma, A. Nasir, K. M. Prabhu, G. Dev, and P. S. Murthy, “Hypoglycemic and hypolipidemic effect of ethanolic extracts of seeds of Eugenia jambolana in alloxan induced diabetic model of rabbits,” Journal of Ethnopharmacology, vol. 85, pp. 201–206, 2003. View at Google Scholar
  8. K. Ravi, K. Sivagnanam, and S. Subramanian, “Anti-diabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats,” Journal of Medicinal Food, vol. 7, no. 2, pp. 187–191, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Ravi, S. Rajasekaran, and S. Subramanian, “Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats,” Food and Chemical Toxicology, vol. 43, no. 9, pp. 1433–1439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. B. Sridhar, U. D. Sheetal, M. R. S. M. Pai, and M. S. Shastri, “Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 3, pp. 463–468, 2005. View at Google Scholar · View at Scopus
  11. B. Sharma, C. Balomajumder, and P. Roy, “Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats,” Food and Chemical Toxicology, vol. 46, no. 7, pp. 2376–2383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. B. Sharma, A. Nasir, K. M. Prabhu, and P. S. Murthy, “Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus,” Journal of Ethnopharmacology, vol. 104, no. 3, pp. 367–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. F. L. Bishop and G. T. Lewith, “Who uses CAM a narrative review of demographic characteristics and health factors associated with CAM use,” Evidence-based Complementary and Alternative Medicine, vol. 7, no. 1, pp. 11–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Harris and R. Rees, “The prevalence of complementary and alternative medicine use among the general population: A systematic review of the literature,” Complementary Therapies in Medicine, vol. 8, no. 2, pp. 88–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kiat and Y. S. Bin, “Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 632829, 12 pages, 2011. View at Publisher · View at Google Scholar
  16. M. Bhat, S. K. Kothiwale, A. R. Tirmale, S. Y. Bhargava, and B. N. Joshi, “Antidiabetic properties of Azardiracta indica and Bougainvillea spectabilis: in vivo studies in murine diabetes model,” Evidence-Based Complementary and Alternative Medicine. In press.
  17. O. Said, S. Fulder, K. Khalil, H. Azaizeh, E. Kassis, and B. Saad, “Maintaining a physiological blood glucose level with 'glucolevel', a combination of four anti-diabetes plants used in the traditional Arab herbal medicine,” Evidence-based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 421–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Ghosh, D. De, K. Chatterjee, K. M. Ali, and T. K. Bera, “Antidiabetic potentiality of the aqueous-methanolic extract of seed of Swietenia mahagoni (L.) Jacq. in streptozotocin-induced diabetic male albino rat: a correlative and evidence-based approach with antioxidative and antihyperlipidemic activities,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 892807, 11 pages, 2011. View at Publisher · View at Google Scholar
  19. M. Bhat, S. K. Kothiwale, A. R. Tirmale, S. Y. Bhargava, and B. N. Joshi, “Antidiabetic properties of Azardiracta indica and Bougainvillea spectabilis: in vivo studies in murine diabetes model,” Evidence-Based Complementary and Alternative Medicine. In press.
  20. M. Zimmermann, “Ethical guidelines for investigations of experimental pain in conscious animals,” Pain, vol. 16, no. 2, pp. 109–110, 1983. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Siddiqui, Y. Sun, J. C. Liu, and Y. W. Chien, “Facilitated transdermal transport of insulin,” Journal of Pharmaceutical Sciences, vol. 76, no. 4, pp. 341–345, 1987. View at Google Scholar · View at Scopus
  22. D. A. Sorg and B. Buckner, “A simple method of obtaining venous blood from small laboratory animals,” Proceedings of the Society for Experimental Biology and Medicine, vol. 115, pp. 1131–1132, 1964. View at Google Scholar
  23. D. Barham and P. Trinder, “An improved colour reagent for the determination of blood glucose by the oxidase system,” The Analyst, vol. 97, no. 1151, pp. 142–145, 1972. View at Google Scholar · View at Scopus
  24. P. Fossati and L. Prencipe, “Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide,” Clinical Chemistry, vol. 28, no. 10, pp. 2077–2080, 1982. View at Google Scholar · View at Scopus
  25. C. C. Allain, L. S. Poon, and C. S. G. Chan, “Enzymatic determination of total serum cholesterol,” Clinical Chemistry, vol. 20, no. 4, pp. 470–475, 1974. View at Google Scholar · View at Scopus
  26. M. Burstein, H. R. Scholnick, and R. Morfin, “Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions,” Journal of Lipid Research, vol. 11, no. 6, pp. 583–595, 1970. View at Google Scholar · View at Scopus
  27. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  28. H. Moshage, B. Kok, J. R. Huizenga, and P. L. M. Jansen, “Nitrite and nitrate determinations in plasma: a critical evaluation,” Clinical Chemistry, vol. 41, no. 6, pp. 892–896, 1995. View at Google Scholar · View at Scopus
  29. M. Ahotupa, M. Ruutu, and E. Mäntylä, “Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins,” Clinical Biochemistry, vol. 29, no. 2, pp. 139–144, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Choudhary, “Beneficial effect of Allium sativum and Allium tuberosum on experimental hyperlipidemia and atherosclerosis,” Pakistan Journal of Physiology, vol. 4, pp. 7–9, 2009. View at Google Scholar
  31. W. B. Kannel, “Lipids, diabetes, and coronary heart disease: insights from the Framingham study,” American Heart Journal, vol. 110, no. 5, pp. 1100–1107, 1985. View at Google Scholar · View at Scopus
  32. A. J. Garber, “Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice,” Diabetes, Obesity and Metabolism, vol. 4, no. 1, pp. S5–S12, 2002. View at Google Scholar · View at Scopus
  33. F. Parhami, Z. T. Fang, A. M. Fogelman, A. Andalibi, M. C. Territo, and J. A. Berliner, “Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate,” Journal of Clinical Investigation, vol. 92, no. 1, pp. 471–478, 1993. View at Google Scholar · View at Scopus
  34. D. J. Rader, J. M. Hoeg, and H. B. Brewer, “Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease,” Annals of Internal Medicine, vol. 120, no. 12, pp. 1012–1025, 1994. View at Google Scholar · View at Scopus
  35. B. Lamarche, S. Moorjani, P. J. Lupien et al., “Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study,” Circulation, vol. 94, no. 3, pp. 273–278, 1996. View at Google Scholar · View at Scopus
  36. G. Walldius, I. Jungner, I. Holme, A. H. Aastveit, W. Kolar, and E. Steiner, “High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study,” Lancet, vol. 358, no. 9298, pp. 2026–2033, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Lorkowska, M. Bartus, M. Franczyk et al., “Hypercholesterolemia does not alter endothelial function in spontaneously hypertensive rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 3, pp. 1019–1026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Singhania, D. Puri, S. V. Madhu, and S. B. Sharma, “Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy,” QJM, vol. 101, no. 6, pp. 449–455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. T. W. Meade, M. V. Vickers, and S. G. Thompson, “Epidemiological characteristics of platelet aggregability,” British Medical Journal, vol. 290, no. 6466, pp. 428–432, 1985. View at Google Scholar
  40. R. Ross, J. Glomset, B. Kariya, and L. Harker, “A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 4, pp. 1207–1210, 1974. View at Google Scholar · View at Scopus